Back to newsBraveheart Bio, Inc. <BRVE.O>: Jefferies initiates coverage with buy rating; target price $48BBRVE•2026-08-31Related NewsTIs Fed communication broken — and can Warsh fix it?: McGeever
BRVE•BRVE•BRVE•BRVE•
